NCT03280264 2021-05-27Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary HyperparathyroidismKyowa Kirin Co., Ltd.Phase 3 Completed18 enrolled 13 charts